Latest Perth News

Nyrada has moved its PROTECT-MI heart-attack trial into active recruitment, with four hospitals open and three patients dosed. The biotech also reported supportive US FDA feedback, encouraging preclinical oncology data and AU$13.72 million in cash after a AU$12 million placement.

Indiana Resources has completed drilling at Company Well and Minos, while heritage clearance unlocks the next stage at the 7km Ealbara gold anomaly. The exploration progress comes alongside a November CEO departure and an unresolved arbitration claim over US$13.05 million in Tanzania settlement proceeds.

Charter Hall Long WALE REIT has maintained its FY27 operating earnings and distribution guidance at 25.5 cents per security after delivering 2% FY26 growth. A cheaper, longer-dated debt platform and a $6.1 billion portfolio give the REIT more financial flexibility, although the outlook still depends on execution and property valuations.

Vault Minerals has completed dispatch of the scheme booklet for its proposed merger with Genesis Minerals, moving the transaction into its decisive shareholder-vote phase. An independent expert has backed the deal as being in shareholders’ best interests, subject to no superior offer emerging.

Native Mineral Resources has surpassed 6,000oz of refined gold production at Blackjack, while its latest weekly smelt produced 527.6oz of doré. October’s record ambitions now depend on Perth Mint results and two remaining smelts.

Finbar has completed its largest-ever apartment development by lot count, issuing titles for the 342-lot Garden Towers project in East Perth and opening the way for settlements. The 50% joint venture is 82% sold, with $210 million in sales recorded to date and revenue recognition expected in H1 FY27.

Central Asia Metals has secured the Kazakhstan regulatory approval required for its proposed acquisition of Cygnus Metals, removing a key condition before tomorrow’s Second Court Hearing. The scheme remains subject to the court process and any remaining conditions, with implementation still targeted for 27 October.

XRF Scientific has delivered its strongest September quarter in years, with revenue rising 38% to $21.1 million and profit before tax climbing 30% to $4.4 million. Orbis growth, resilient consumables demand and the developing CGA business are giving the company several avenues for further expansion, although precious metals revenue included a low-margin one-off sale.

Midas Minerals has extended confirmed mineralisation at its Spaatzu copper-silver deposit in Namibia to 1.5 kilometres, with broad shallow intercepts continuing to emerge from step-out drilling. Assays from another 19 holes are pending ahead of a planned initial resource estimate in the first quarter of 2027.

Emyria’s FY26 annual report shows a rapidly expanding psychedelic-assisted care network, with revenue up 210% and treatment capacity reaching 18 beds across four states. The gains came alongside a larger loss, $4.6 million in operating cash outflow and an auditor-highlighted material uncertainty over the company’s ability to continue without further funding.

Simonds Group delivered a sharp FY26 earnings rebound, with NPAT rising 950% to $10.5 million as revenue, site starts and margins all improved. The annual report also flags a qualified sustainability reporting outcome and a new Western Australian venture that will require execution and cash.

Aspen Group delivered a sharp rise in FY26 earnings and distributions, then lifted its FY27 targets despite a softer residential sales market. The property group is expanding its affordable rental and development platform, but debt and valuation sensitivity are rising with it.